Pharmacy Benefit Managers Are Again In The Crosshairs Of Congress And The FTC: Action To Reform Drug Pricing Increasingly Likely Read more
Biden’s SOTU Targets Drug Companies, But Misses Opportunity To Challenge Health Insurers And Pharmacy Benefit Managers Read more
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita Read more
How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 1) Read more